July 06, 2016
A Manhattan federal judge on Wednesday ditched a proposed class action alleging that the former CEO of a bankrupt pharmaceutical company had lied about the efficacy of an intended dual painkiller treatment before pulling it from development, saying the cited statements were not misleading.
June 24, 2015
A bankrupt Australian pharmaceutical company that hoped to produce the world's first dual painkiller treatment was sued in New York federal court Tuesday, with investors saying the company lied about the drug's efficacy before pulling it from development.